Education Programme on Continuous Positive Airway Pressure Treatment
Launched by THE UNIVERSITY OF HONG KONG · Jul 30, 2010
Trial Information
Current as of June 03, 2025
Completed
Keywords
ClinConnect Summary
Obstructive sleep apnoea (OSA) is a common sleep disorders associated with excessive daytime sleepiness and cardiovascular disease. It is prevalent both in populations of western and eastern countries. Continuous positive airway pressure (CPAP) therapy is an effective standard treatment and is widely prescribed for patients with OSA. However, the use of CPAP for such patients is disappointingly low. Low patient CPAP adherence limits the effectiveness of treatment. To determine whether there is a need for an extended education programme for the OSA patient in order to improve CPAP usage.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Aged 18 years or over.
- • 2. Newly diagnosed of OSA and will be starting CPAP therapy
- Exclusion Criteria:
- • 1. Not suitable for CPAP therapy
- • 2. Previously received CPAP therapy
- • 3. Possesses restrictive and obstructive pulmonary diseases
- • 4. Possesses hypoventilation
- • 5. Under unstable health conditions
- • 6. pregnant
- • 7. History of psychiatric illness
About The University Of Hong Kong
The University of Hong Kong (HKU) is a leading research institution dedicated to advancing medical knowledge and improving healthcare outcomes through innovative clinical trials. With a commitment to excellence in research and education, HKU collaborates with various stakeholders, including healthcare providers and industry partners, to conduct rigorous and ethically sound clinical studies. The university's diverse expertise and state-of-the-art facilities enable it to explore a wide range of therapeutic areas, contributing to the global pursuit of scientific advancement and the development of novel treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hong Kong Island, , Hong Kong
Patients applied
Trial Officials
Agnes YK Lai, MSc
Principal Investigator
The University of Hong Kong
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials